Activation of NHRs leads to neuronal differentiation and reduced tumor burden in neuroblastoma
Aug. 4, 2022
It has been previously demonstrated that MYCN amplification frequently occurs in high-risk neuroblastoma (NB), and it is correlated with an undifferentiated phenotype and poor prognosis.
